Observational Study
Copyright ©The Author(s) 2025.
World J Clin Pediatr. Sep 9, 2025; 14(3): 102309
Published online Sep 9, 2025. doi: 10.5409/wjcp.v14.i3.102309
Table 6 Correlation of pepsin in sample A, B and C with other studied parameters among the studied cases
Sample A ETA pepsin (ng/mL)
Sample B ETA pepsin (ng/mL)
Sample C ETA pepsin (ng/mL)
r
P value
r
P value
r
P value
Age on intubation (days)-0.0270.7910.0820.429-0.1700.164
Birth weight0.0100.9190.1550.132-0.1370.261
APGAR score at 1 minute-0.0820.4260.0270.7950.0080.951
APGAR score at 5 minutes-0.0200.847-0.0620.5490.0870.476
Proton pump inhibitor (days)-0.0040.9810.0540.748-0.0490.816
Prokinetic drugs (days)0.0050.976-0.0500.784-0.2300.259
Duration of MV (days)0.0800.4380.1300.208-0.1290.292
FiO20.1660.1040.2030.047a0.1930.112
Amount of feeding (mL/day)-0.2100.039a-0.2340.022a-0.2670.027a
Duration of hospital stay (days)0.0310.7660.2880.004a0.5590.000a